Cellivery has ranked among the top searched stocks on 5 days within the past month.

As of 9:30 AM on the 19th, Cellivery is trading at 144,600 KRW, up 2.7% from the previous day. This marks a 47.25% increase compared to July 24.

Over the past 5 days, individual investors have net purchased 297 shares, while foreigners and institutions have net purchased 19,012 shares and 533 shares, respectively.

On August 13, Cellivery made headlines in the market with the news, "Producing capsule-type obesity treatment to compete with Saxenda, a 1 trillion KRW sales obesity drug..."

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing